Picture of Kainos Laboratories logo

4556 — Kainos Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMicro CapNeutral

Table: Kainos -2019/20 parent results

May 8 (Reuters)- 
          Kainos Laboratories Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           4.61            4.67           4.50          2.10    
               (-1.3 pct)      (+6.5 pct)     (-2.4 pct)    (-7.8 pct) 
  Operating      608 mln         581 mln        450 mln      220 mln   
               (+4.7 pct)      (+27.4 pct)    (-26.1 pct)  (-31.5 pct) 
  Recurring      616 mln         596 mln        450 mln      220 mln   
               (+3.3 pct)      (+25.0 pct)    (-27.0 pct)  (-31.5 pct) 
  Net            398 mln         385 mln        300 mln      140 mln   
               (+3.3 pct)      (+38.9 pct)    (-24.7 pct)  (-36.7 pct) 
  EPS           97.09 yen       98.57 yen      71.74 yen    33.48 yen  
  Ann Div       15.00 yen       15.00 yen      15.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       15.00 yen       15.00 yen      15.00 yen               
  
  NOTE - Kainos Laboratories Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T

Recent news on Kainos Laboratories

See all news